Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Danita M. Yoerger Sanborn, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Cohen JA, Heist EK, Galvin J, Lee H, Johnson M, Fitzsimons M, Slattery K, Ghoshhajra B, Sakhuja R, Ha G, Forsch M, Shi L, Danik J, Dal-Bianco J, Sanborn D, Hung J, Ruskin J, Gurol ME, Mansour M. A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantation. Pacing Clin Electrophysiol. 2019 10; 42(10):1304-1309. PMID: 31479160.
  2. Te Riele ASJM, Tandri H, Sanborn DM, Bluemke DA. Noninvasive Multimodality Imaging in ARVD/C. JACC Cardiovasc Imaging. 2015 May; 8(5):597-611. PMID: 25937197.
    Citations: 5     Fields:    Translation:Humans
  3. Rothman RD, Baggish AL, O'Callaghan C, Lowry PA, Bhatt AB, MacRae CA, Yannekis G, Sanborn DM, Mela T, Yeh RW, Palacios I, Vlahakes GJ, Fifer MA. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Am J Cardiol. 2012 Oct 15; 110(8):1169-74. PMID: 22766229.
    Citations:    Fields:    Translation:Humans
  4. Sanborn DMY, Sigwart U, Fifer MA. Patient selection for alcohol septal ablation for hypertrophic obstructive cardiomyopathy: clinical and echocardiographic evaluation. Interventional Cardiology. 2012; 4(3):349-59.
  5. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010 Apr; 31(7):806-14. PMID: 20172912.
    Citations: 157     Fields:    Translation:Humans
  6. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010 Apr 06; 121(13):1533-41. PMID: 20172911.
    Citations: 261     Fields:    Translation:HumansCTClinical Trials
  7. Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2009 Jul 01; 104(1):128-32. PMID: 19576333.
    Citations: 12     Fields:    Translation:Humans
  8. Marcus FI, Zareba W, Calkins H, Towbin JA, Basso C, Bluemke DA, Estes NA, Picard MH, Sanborn D, Thiene G, Wichter T, Cannom D, Wilber DJ, Scheinman M, Duff H, Daubert J, Talajic M, Krahn A, Sweeney M, Garan H, Sakaguchi S, Lerman BB, Kerr C, Kron J, Steinberg JS, Sherrill D, Gear K, Brown M, Severski P, Polonsky S, McNitt S. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009 Jul; 6(7):984-92. PMID: 19560088.
    Citations: 40     Fields:    Translation:Humans
  9. Delling FN, Sanborn DY, Levine RA, Picard MH, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Vaturi M, Hung J. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2007 Dec 01; 100(11):1691-5. PMID: 18036370.
    Citations: 7     Fields:    Translation:Humans
  10. Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, Lewandrowski KB, Siegel AJ, Marshall JE, Douglas PS, Lawlor D, Picard MH, Wood MJ. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation. 2006 Nov 28; 114(22):2325-33. PMID: 17101848.
    Citations: 89     Fields:    Translation:Humans
  11. Neilan TG, Ton-Nu TT, Jassal DS, Popovic ZB, Douglas PS, Halpern EF, Marshall JE, Thomas JD, Picard MH, Yoerger DM, Wood MJ. Myocardial adaptation to short-term high-intensity exercise in highly trained athletes. J Am Soc Echocardiogr. 2006 Oct; 19(10):1280-5. PMID: 17000368.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  12. Baggish AL, Smith RN, Palacios I, Vlahakes GJ, Yoerger DM, Picard MH, Lowry PA, Jang IK, Fifer MA. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart. 2006 Dec; 92(12):1773-8. PMID: 16807273.
    Citations: 9     Fields:    Translation:Humans
  13. Ellinor PT, Sasse-Klaassen S, Probst S, Gerull B, Shin JT, Toeppel A, Heuser A, Michely B, Yoerger DM, Song BS, Pilz B, Krings G, Coplin B, Lange PE, Dec GW, Hennies HC, Thierfelder L, MacRae CA. A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26. J Am Coll Cardiol. 2006 Jul 04; 48(1):106-11. PMID: 16814656.
    Citations: 9     Fields:    Translation:HumansCells
  14. Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J. 2006 Aug; 27(15):1805-10. PMID: 16774986.
    Citations: 6     Fields:    Translation:Humans
  15. Jassal DS, Neilan TG, Fatima U, Holmvang G, Agnihotri A, Palacios I, Yoerger DM. Mitral valve ring dehiscence with an aorta-left atrial fistula. Eur J Echocardiogr. 2007 Aug; 8(4):296-8. PMID: 16697261.
    Citations:    Fields:    Translation:HumansCells
  16. Yoerger DM, Best CA, McQuillan BM, Supple GE, Guererro JL, Cluette-Brown JE, Hasaba A, Picard MH, Stone JR, Laposata M. Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery. Am J Pathol. 2006 May; 168(5):1435-42. PMID: 16651611.
    Citations: 5     Fields:    Translation:AnimalsCells
  17. Yoerger DM, Picard MH, Palacios IF, Vlahakes GJ, Lowry PA, Fifer MA. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006 May 15; 97(10):1511-4. PMID: 16679095.
    Citations: 7     Fields:    Translation:Humans
  18. Neilan TG, Yoerger DM, Douglas PS, Marshall JE, Halpern EF, Lawlor D, Picard MH, Wood MJ. Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J. 2006 May; 27(9):1079-84. PMID: 16554314.
    Citations: 46     Fields:    Translation:Humans
  19. Chen AA, Palacios IF, Mela T, Yoerger DM, Picard MH, Vlahakes G, Lowry PA, Fifer MA. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006 Jan 15; 97(2):264-9. PMID: 16442376.
    Citations: 3     Fields:    Translation:Humans
  20. Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet. 2005 Nov; 118(2):179-84. PMID: 16133178.
    Citations: 83     Fields:    Translation:Humans
  21. Yoerger DM, Marcus F, Sherrill D, Calkins H, Towbin JA, Zareba W, Picard MH. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol. 2005 Mar 15; 45(6):860-5. PMID: 15766820.
    Citations: 30     Fields:    Translation:Humans
  22. Delgado G, Inglessis I, Martin-Herrero F, Yoerger D, Liberthson R, Buoanno F, Palacios I. Management of platypnea-orthodeoxia syndrome by transcatheter closure of atrial communication: hemodynamic characteristics, clinical and echocardiographic outcome. J Invasive Cardiol. 2004 Oct; 16(10):578-82. PMID: 15505355.
    Citations: 7     Fields:    Translation:Humans
  23. Fifer MA, Yoerger DM, Picard MH, Vlahakes GJ, Palacios IF. Images in cardiovascular medicine. Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: initial success but ultimate failure resulting from collateral formation. Circulation. 2003 Jul 01; 107(25):3248-9. PMID: 12835408.
    Citations: 4     Fields:    Translation:Humans
  24. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA. Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation. 2003 Jun 17; 107(23):2880-3. PMID: 12782570.
    Citations: 46     Fields:    Translation:HumansCells
  25. Lowe HC, Jang IK, Yoerger DM, MacGillivray TE, de Moor M, Palacios IF. Compassionate use of the amplatzer ASD closure device for residual postinfarction ventricular septal rupture following surgical repair. Catheter Cardiovasc Interv. 2003 Jun; 59(2):230-3; discussion 234. PMID: 12772247.
    Citations:    Fields:    Translation:Humans
  26. Braun A, Zhang S, Miettinen HE, Ebrahim S, Holm TM, Vasile E, Post MJ, Yoerger DM, Picard MH, Krieger JL, Andrews NC, Simons M, Krieger M. Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci U S A. 2003 Jun 10; 100(12):7283-8. PMID: 12771386.
    Citations: 40     Fields:    Translation:HumansAnimalsCells
  27. Yoerger DM, Weyman AE. Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy. Rev Cardiovasc Med. 2003; 4(4):199-215. PMID: 14668688.
    Citations: 3     Fields:    Translation:Humans
  28. Laposata M, Hasaba A, Best CA, Yoerger DM, McQuillan BM, Salem RO, Refaai MA, Soderberg BL. Fatty acid ethyl esters: recent observations. Prostaglandins Leukot Essent Fatty Acids. 2002 Aug-Sep; 67(2-3):193-6. PMID: 12324241.
    Citations: 2     Fields:    Translation:HumansCells
  29. Caterine MR, Yoerger DM, Spencer KT, Miller SG, Kerber RE. Effect of electrode position and gel-application technique on predicted transcardiac current during transthoracic defibrillation. Ann Emerg Med. 1997 May; 29(5):588-95. PMID: 9140241.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  30. Kerber RE, Spencer KT, Kallok MJ, Birkett C, Smith R, Yoerger D, Kieso RA. Overlapping sequential pulses. A new waveform for transthoracic defibrillation. Circulation. 1994 May; 89(5):2369-79. PMID: 8181163.
    Citations: 3     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sanborn's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (189)
Co-Authors (40)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.